A participant in a virtual study run by the California firm Science 37 receives materials at home. Credit: Christian Alexander In the midst of the coronavirus pandemic, there has been a desire to continue to conduct ongoing clinical trials while maintaining social distancing as much as possible. Clinical trial participants have been hesitant to attend … Continue reading The growth of virtual clinical trials during COVID-19
drug development
Four Challenges to Making the Best Stem Cell Models for Brain Diseases
Neurological diseases are complicated. A single genetic mutation causes some, while multiple genetic and environmental factors cause others. Also, within a single neurological disease, patients can experience varying symptoms and degrees of disease severity. And you can’t just open up the brain and poke around to see what’s causing the problem in living patients. It’s … Continue reading Four Challenges to Making the Best Stem Cell Models for Brain Diseases
Bringing out the Big Guns: Scientists Weigh in on How Best to Combat Deadly Diseases of the Brain
Despite our best efforts, diseases of the brain are on the rise. Neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases threaten not only to devastate our aging population, but also cripple our economy. Meanwhile, the causes of conditions such as autism remain largely unknown. And brain and spinal cord injuries continue to increase—leaving their victims … Continue reading Bringing out the Big Guns: Scientists Weigh in on How Best to Combat Deadly Diseases of the Brain
The Stem Cellar 